Literature DB >> 29744239

Neuromuscular Block and Blocking Agents in 2018.

Christoph Unterbuchner1.   

Abstract

Year:  2018        PMID： 29744239      PMCID： PMC5937467          DOI： 10.5152/TJAR.2018.200318

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN： 2149-276X


× No keyword cloud information.
  79 in total

1.  Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit.

Authors:  Glenn S Murphy; Joseph W Szokol; Jesse H Marymont; Steven B Greenberg; Michael J Avram; Jeffery S Vender; Margarita Nisman
Journal:  Anesthesiology       Date:  2008-09       Impact factor: 7.892

2.  Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.

Authors:  Hans Kirkegaard; Tom Heier; James E Caldwell
Journal:  Anesthesiology       Date:  2002-01       Impact factor: 7.892

Review 3.  Neuromuscular Monitoring in the Perioperative Period.

Authors:  Glenn S Murphy
Journal:  Anesth Analg       Date:  2018-02       Impact factor: 5.108

4.  "To Reverse or Not To Reverse?": The Answer Is Clear!

Authors:  Glenn S Murphy; Aaron F Kopman
Journal:  Anesthesiology       Date:  2016-10       Impact factor: 7.892

Review 5.  Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation.

Authors:  J M Hunter
Journal:  Br J Anaesth       Date:  2017-12-01       Impact factor: 9.166

Review 6.  [Deep neuromuscular blockade : Benefits and risks].

Authors:  C Unterbuchner; M Blobner
Journal:  Anaesthesist       Date:  2018-03       Impact factor: 1.041

7.  Tactile and visual evaluation of the response to train-of-four nerve stimulation.

Authors:  J Viby-Mogensen; N H Jensen; J Engbaek; H Ording; L T Skovgaard; B Chraemmer-Jørgensen
Journal:  Anesthesiology       Date:  1985-10       Impact factor: 7.892

8.  A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.

Authors:  G Geldner; M Niskanen; P Laurila; V Mizikov; M Hübler; G Beck; H Rietbergen; E Nicolayenko
Journal:  Anaesthesia       Date:  2012-06-14       Impact factor: 6.955

9.  Clinical concentrations of edrophonium enhance desensitization of the nicotinic acetylcholine receptor.

Authors:  C S Yost; E Maestrone
Journal:  Anesth Analg       Date:  1994-03       Impact factor: 5.108

10.  Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.

Authors:  Karin S Khuenl-Brady; Magnus Wattwil; Bernard F Vanacker; José I Lora-Tamayo; Henk Rietbergen; José A Alvarez-Gómez
Journal:  Anesth Analg       Date:  2009-08-27       Impact factor: 5.108
View more
  2 in total

Review 1.  [Algorithm-based preventive strategies for avoidance of residual neuromuscular blocks].

Authors:  C Unterbuchner; K Ehehalt; B Graf
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

2.  Predictive study of pharmacological reversal for residual neuromuscular blockade and postoperative pulmonary complications: a prospective, observational, cohort study.

Authors:  Cristian Aragón-Benedí; Ana Pascual-Bellosta; Sonia Ortega-Lucea; Sara Visiedo-Sánchez; Javier Martínez-Ubieto
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.